This is a QR code. A QR Code is a 2-dimensional barcode, which has encoded in it a URL (web address), text, or other information. It can be read by a QR code scanner, including QR scanner smartphone apps. Once you have an app installed on your smartphone, open the app and hold your phones camera over a QR code to read it. Most QR codes youll come across have a URL encoded, so chances are when you read the QR code it will take you to a web page.
Reviewed by members of Editorial board for inclusion in MERLOT.
Very good quality; in queue to be peer reviewed
Click to get more information on the MERLOT Editors' Choice Award in a new window.
Click to get more information on the MERLOT Classics Award in a new window.
Click to get more information on the MERLOT JOLT Award in a new window.
Search all MERLOT
Click here to go to your profile
Click to expand login or register menu
Select to go to your workspace
Click here to go to your Dashboard Report
Click here to go to your Content Builder
Click here to log out
Please give at least one keyword of at least three characters for the search to work with. The more keywords you give, the better the search will work for you.
select OK to launch help window
You are now going to MERLOT Help. It will open in a new window
For optimal performance of MERLOT functionality, use IE 9 or higher, or Safari on mobile devices
A few years ago, a clinical trial began in France in the hope of curing children with a type of genetic immune deficiency called SCID-X1. Children with this disease have a defective gene, called gamma-c, which prevents a subset of the cells of the immune system from forming, and predisposes the children to life-threatening...
A few years ago, a clinical trial began in France in the hope of curing children with a type of genetic immune deficiency called SCID-X1. Children with this disease have a defective gene, called gamma-c, which prevents a subset of the cells of the immune system from forming, and predisposes the children to life-threatening infections. In an attempt to cure the children?who would otherwise die at a young age?physicians used gene therapy to provide them with normal gamma-c genes.
This particular trial has had striking success as well as tragedy. Eight of the eleven children are currently thriving. However, in two cases the therapy successfully introduced gamma-c genes, but these children have since developed leukemia. In both children, a gamma-c gene inserted next to another gene, called LMO2. The LMO2 gene has previously been linked to leukemia, and scientists speculate that the insertion of the gamma-c gene next to LMO2 may have overstimulated the gene, causing T cells to proliferate in excess. An LMO2 effect, in combination with the proliferation-inducing effects of the gamma-c gene itself, may be the cause of the leukemia in these two patients. Scientists are still investigating other possible causes.
From this single trial, it is clear that gene therapy holds significant promise, yet it is also clear that it poses significant risks.